94 related articles for article (PubMed ID: 24950623)
1. Genetic variants and evolutionary analyses of heparin cofactor II.
Kumar A; Bhandari A; Sarde SJ; Goswami C
Immunobiology; 2014 Sep; 219(9):713-28. PubMed ID: 24950623
[TBL] [Abstract][Full Text] [Related]
2. Revising angiotensinogen from phylogenetic and genetic variants perspectives.
Kumar A; Sarde SJ; Bhandari A
Biochem Biophys Res Commun; 2014 Apr; 446(2):504-18. PubMed ID: 24631685
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): molecular characterization, cloning and expression analysis.
Umasuthan N; Whang I; Lee Y; Lee S; Kim Y; Kim H; Jung SJ; Oh MJ; Choi CY; Yeo SY; Lee SJ; Lee J
Fish Shellfish Immunol; 2011 Jan; 30(1):194-208. PubMed ID: 20951808
[TBL] [Abstract][Full Text] [Related]
4. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
5. Sequence, phylogenetic and variant analyses of antithrombin III.
Kumar A; Bhandari A; Sarde SJ; Goswami C
Biochem Biophys Res Commun; 2013 Nov; 440(4):714-24. PubMed ID: 24121110
[TBL] [Abstract][Full Text] [Related]
6. Isolation of frog and chicken cDNAs encoding heparin cofactor II.
Colwell NS; Tollefsen DM
Thromb Haemost; 1998 Nov; 80(5):784-90. PubMed ID: 9843172
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
8. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
[TBL] [Abstract][Full Text] [Related]
9. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and expression of rabbit heparin cofactor II: a plasma thrombin inhibitor highly conserved between species.
Sheffield WP; Schuyler PD; Blajchman MA
Thromb Haemost; 1994 Jun; 71(6):778-82. PubMed ID: 7974347
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a novel isoform of heparin cofactor II in human liver.
Bano S; Fatima S; Ahamad S; Ansari S; Gupta D; Tabish M; Rehman SU; Jairajpuri MA
IUBMB Life; 2020 Oct; 72(10):2180-2193. PubMed ID: 32827448
[TBL] [Abstract][Full Text] [Related]
12. Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
Zhang GS; Mehringer JH; Van Deerlin VM; Kozak CA; Tollefsen DM
Biochemistry; 1994 Mar; 33(12):3632-42. PubMed ID: 7908224
[TBL] [Abstract][Full Text] [Related]
13. Molecular phylogeny of C1 inhibitor depicts two immunoglobulin-like domains fusion in fishes and ray-finned fishes specific intron insertion after separation from zebrafish.
Kumar A; Bhandari A; Sarde SJ; Goswami C
Biochem Biophys Res Commun; 2014 Jul; 450(1):219-26. PubMed ID: 24878530
[TBL] [Abstract][Full Text] [Related]
14. Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance.
Cunningham MA; Bhakta V; Sheffield WP
Thromb Haemost; 2002 Jul; 88(1):89-97. PubMed ID: 12152684
[TBL] [Abstract][Full Text] [Related]
15. Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes.
Maekawa H; Tollefsen DM
J Biol Chem; 1996 Aug; 271(31):18604-9. PubMed ID: 8702511
[TBL] [Abstract][Full Text] [Related]
16. Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin.
Sheffield WP; Blajchman MA
FEBS Lett; 1995 May; 365(2-3):189-92. PubMed ID: 7781777
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
Kondo S; Tokunaga F; Kario K; Matsuo T; Koide T
Blood; 1996 Feb; 87(3):1006-12. PubMed ID: 8562924
[TBL] [Abstract][Full Text] [Related]
18. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
19. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
[TBL] [Abstract][Full Text] [Related]
20. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
Ciaccia AV; Monroe DM; Church FC
J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
